Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 70, Issue 3, 2002, Pages 201-205

  Mwanatambwe, Milanga ^a   Yajima, Mikihisa ^b   Etuaful, Samuel ^c   Fukunishi, Yukiko ^d   Suzuki, Keiji ^b   Asiedu, Kingsley ^e   Yamada, Nobutaka ^a   Asanao, Goro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b National Leprosarium   (Japan)

^c Agroyesum St Martin Hospital   (South Africa)

^d National Sanatorium   (Japan)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; MONOCLONAL ANTIBODY; PHENOLIC GLYCOLIPID I; POLYKETIDE; SUGAR; TRISACCHARIDE;

ACID FAST BACTERIUM; ARTICLE; BURULI ULCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEPROSY; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM ULCERANS; NODULATION; PATHOGENESIS; SKIN CULTURE; TROPICS; TUBERCULOSIS; ULCER; ULCER HEALING;

ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; GHANA; GLYCOLIPIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM ULCERANS;

EID: 0036760651     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Asiedu, K. and Etuaful, S. Socioeconomic implications of Buruli ulcer in Ghana: A three-year review. Am. J. Trop. Med. Hyg. 59 (1998) 1015-1022.
2. Connor, D. H. and Lunn, H. F. Buruli ulceration. A clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration. Arch. Path. 81 (1966) 183-199.
3. Fujiwara, T., Minagawa, F., Sakamoto, Y. and Douglas, J. T. Epitope mapping of twelve monoclonal antibodies against the phenolic glycolipid-1 of M. leprae. Int. J. Lepr. 65 (1997) 477-486.
4. Gunawardana, G., Chatterjee, D., George, K. M., Brennan, P., Whittern, D. and Small, P. L. C. Characterization of novel macrolide toxins, mycolactones A and B, from a human pathogen, Mycobacterium ulcerans. J. Am. Chem. Soc. 121 (1999) 6092-6095.
5. Hayman, J. and McQueen, A. The pathology of Mycobacterium ulcerans infection. Pathology 17 (1985) 594-600.
6. Hunter, S. W., Fujiwara, T. and Brennan, P. J. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J. Biol. Chem. 257 (1982) 15072-15078.
7. Mehra, V., Brennan, P. J., Rada, E., Convit, J. and Bloom, B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308 (1984) 194-196.
8. Mwanatambwe, M., Fukunishi, Y., Yajima, M., Suzuki, K., Asiedu, K., Etuaful, S., Yamada, N. and Asano, G. Clinico-histopathological findings of Buruli ulcer. Nikon Hansenbyo Gakkai Zasshi 69 (2000) 93-100.
9. van der Werf, T. S., van der Graaf, W. T. A., Tappero, J. W. and Asiedu, K. Mycobacterium ulcerans infection. Lancet 354 (1999) 1013-1018.
10. Vyberg, M. and Nielsen, S. Dextran polymer conjugate two-step visualization system for immunohistochemistry. A comparison of EnVision+ with two three-step Avidin-Biotin techniques. Appl. Immunohistochem. 6 (1998) 3-10.